InflaRx N.V. (IFRX) Reports Positive Data form Third Cohort of Phase IIa Open-Label Study with Vilobelimab

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. ACN
10. USO

Go back to InflaRx N.V. (IFRX) Reports Positive Data form Third Cohort of Phase IIa Open-Label Study with Vilobelimab

InflaRx (IFRX) Extends Gain, Up 70% Pre-Open

October 28, 2021 7:10 AM EDT

InflaRx (NASDAQ: IFRX) Extends Gain, Up 70% Pre-Open

... More